• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempest Therapeutics, Inc. - Common Stock (NQ:TPST)

2.410 +0.040 (+1.69%)
Streaming Delayed Price Updated: 11:06 AM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempest Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Wednesday's pre-market session: top gainers and losers ↗
February 18, 2026
Via Chartmill
News headline image
Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets
February 11, 2026
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets
February 04, 2026
From Tempest Therapeutics
Via GlobeNewswire
The market is filled with gapping stocks in Thursday's session. ↗
January 22, 2026
Via Chartmill
News headline image
Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders
January 20, 2026
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
November 26, 2025
$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full of short-term unregistered warrants 
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
November 25, 2025
$4.25 million upfront with up to an additional $4.1 million of potential aggregate gross proceeds upon the exercise in full of short-term unregistered warrants 
From Tempest Therapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
November 20, 2025
 
Via Benzinga
News headline image
Tempest Therapeutics Stock Plummets Nearly 50% Amid Shareholder Dilution Fears Following CAR-T Acquisition
November 19, 2025
San Francisco, CA – November 19, 2025 – Tempest Therapeutics, Inc. (NASDAQ: TPST) saw its stock price plummet by a staggering 48.92% today, wiping out nearly half of its market value in a single... 
Via MarketMinute
News headline image
TPST Stock Plummets After Inking Deal To Acquire CAR-T Programs From Privately-Held Firm In All-Stock Transaction ↗
November 19, 2025
The transaction is expected to close in early 2026, provided it receives all required approvals. 
Via Stocktwits
News headline image
Crude Oil Falls Over 2%; Lowe's Shares Gain After Q3 Results ↗
November 19, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
November 19, 2025
 
Via Benzinga
News headline image
Nasdaq Gains Over 100 Points; Target Trims Earnings Forecast ↗
November 19, 2025
 
Via Benzinga
News headline image
Why Tempest Therapeutics (TPST) Stock Is Down 45% Today ↗
November 19, 2025
Tempest Therapeutics shares fell Wednesday after the announcement of an all-stock acquisition of dual-CAR T programs from Factor Bioscience. 
Via Benzinga
News headline image
Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027
November 19, 2025
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update
November 05, 2025
From Tempest Therapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
October 17, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
September 04, 2025
 
Via Benzinga
News headline image
Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update
August 11, 2025
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China
June 30, 2025
From Tempest Therapeutics
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
June 11, 2025
 
Via Benzinga
News headline image
Tempest Announces $4.6 Million Registered Direct Offering of Common Stock
June 11, 2025
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
June 09, 2025
The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
Via Chartmill
News headline image
Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗
June 09, 2025
 
Via Benzinga
News headline image
Get insights into the top gainers and losers of Monday's pre-market session. ↗
June 09, 2025
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
June 09, 2025
 
Via Benzinga
News headline image
Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC
June 05, 2025
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Reports First Quarter 2025 Financial Results and Provides Business Update
May 13, 2025
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting
April 28, 2025
From Tempest Therapeutics
Via GlobeNewswire
News headline image
Tempest Receives Orphan Drug Designation from the FDA for TPST-1495 to Treat Patients with FAP
April 21, 2025
From Tempest Therapeutics
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap